CTSA INFRASTRUCTURE FOR AIDS RESEARCH
CTSA INFRASTRUCTURE FOR AIDS RESEARCH
批准号:
8365156
负责人:
GARY S FIRESTEIN
金额:
$35.68万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-04-01 至 2012-03-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This subproject represents an estimate of the percentage of the CTSA funding that is
being utilized for a broad area of research (AIDS research, pediatric research, or
clinical trials). The Total Cost listed is only an estimate of the amount of CTSA
infrastructure going towards this area of research, not direct funding provided by
the NCRR grant to the subproject or subproject staff.
We have established the San Diego Clinical and Translational Research Institute (San Diego CTRI), with its hub located at the University of California, San Diego (UCSD). This regional center contains two universities (UCSD and San Diego State University), 4 biomedical research institutes (Salk Inst., Burnham Inst., J. Craig Venter Inst., and La Jolla Inst, for Allergy and Immunology), and 3 academic hospitals (UCSD Medical Center, VA Hospital and Rady Children's Hospital), one community health sen/ice (Palomar Pomerado Health) and 2 specialized resources~the San Diego Supercomputer Center and the California Inst, for Telecommunications and Information Technology. The CTSA program encompasses 3 health sciences professional schools (Medicine, Pharmacy, Nursing), nine clinical research PhD programs, and a Masters program in Advanced Clinical Studies. The program goals are to: 1) Provide an academic home for the discipline of clinical and translational science; 2) Establish an integrated educational pipeline to train and support clinical and translational scientists; 3) Develop a robust clinical research infrastructure that replaces silos with integrated research; 4) Enhance bioinformatics capabilities that leverage unique UCSD resources; 5) Develop novel technologies to improve research such as biomarker and imaging; 6) Form a Translational Research Alliance with research institutes and industry; 7) Form a Community Alliance with community physicians and the general public to translate scientific discoveries into best practices, increase research into health care disparities, and involve the general public in biomedical science. The CTSA program will provide the resources to develop the discipline of clinical and translational research. Through the San Diego CTRI, the educational pipeline to train the next generation of clinical and translational scientists will be enhanced. A new K12 program, an expanded K30 program, and the integration of new PhD graduate programs in clinical research highlight the proposed educational plan. The CTRI will transform education in clinical and translational science by coordinating disparate programs, providing breadth of education from high school through pre-doctoral students and providing training to post-doctoral fellows and faculty. The Institute will also transform the conduct of clinical research by providing guidance and support from initial planning through data analysis and sharing. The new structure will foster development of novel technologies to facilitate clinical research and provide support for the services and resources necessary to conduct clinical investigation. We will place special emphasis on several areas of strength such as imaging, biomarkers, community outreach, and the translation of basic science discoveries to clinical science. RELEVANCE (See instructions): The San Diego Clinical Translational Research Institute will transform the clinical research by providing guidance and support from initial planning through data analysis and sharing. It will provide an educational pipeline to train the next generation of clinical and translational scientists and involve the community in setting the direction and priorities of the organization. The Institute will foster development of novel technologies that facilitate clinical research, and provide support for the services needed to conduct clinical investigation and improve health.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pathogenic role of ILC2 in rheumatoid arthritis
-
批准号:10269026
-
项目类别:
-
资助金额:$16.86万
-
财政年份:2020
-
负责人:GARY S FIRESTEIN
-
依托单位:
Pathogenic role of ILC2 in rheumatoid arthritis
-
批准号:10057498
-
项目类别:
-
资助金额:$20.8万
-
财政年份:2020
-
负责人:GARY S FIRESTEIN
-
依托单位:
Joint Bioinformatics and Computational Core of the MARC
-
批准号:10007639
-
项目类别:
-
资助金额:$16.5万
-
财政年份:2018
-
负责人:GARY S FIRESTEIN
-
依托单位:
Joint Bioinformatics and Computational Core of the MARC
-
批准号:10254254
-
项目类别:
-
资助金额:$16.44万
-
财政年份:2018
-
负责人:GARY S FIRESTEIN
-
依托单位:
Joint-location specific pathogenic pathways in rheumatoid arthritis
-
批准号:10647624
-
项目类别:
-
资助金额:$34.76万
-
财政年份:2018
-
负责人:GARY S FIRESTEIN
-
依托单位:
Joint Bioinformatics and Computational Core of the MARC
-
批准号:10472687
-
项目类别:
-
资助金额:$16.31万
-
财政年份:2018
-
负责人:GARY S FIRESTEIN
-
依托单位:
Joint-location specific pathogenic pathways in rheumatoid arthritis
-
批准号:9921295
-
项目类别:
-
资助金额:$34.65万
-
财政年份:2018
-
负责人:GARY S FIRESTEIN
-
依托单位:
Identifying synergistic therapeutic targets in RA using systems biology
-
批准号:9164023
-
项目类别:
-
资助金额:$20.46万
-
财政年份:2016
-
负责人:GARY S FIRESTEIN
-
依托单位:
UC San Diego Clinical and Translational Research Institute
-
批准号:10400206
-
项目类别:
-
资助金额:$922.81万
-
财政年份:2015
-
负责人:GARY S FIRESTEIN
-
依托单位:
UC San Diego Clinical and Translational Research Institute
-
批准号:10155614
-
项目类别:
-
资助金额:$904.88万
-
财政年份:2015
-
负责人:GARY S FIRESTEIN
-
依托单位:
UC San Diego Clinical and Translational Research Institute
-
批准号:9126629
-
项目类别:
-
资助金额:$838.35万
-
财政年份:2015
-
负责人:GARY S FIRESTEIN
-
依托单位:
UC San Diego Clinical and Translational Research Institute
-
批准号:9085716
-
项目类别:
-
资助金额:$796.32万
-
财政年份:2015
-
负责人:GARY S FIRESTEIN
-
依托单位:
UC San Diego Clinical and Translational Research Institute
-
批准号:10733080
-
项目类别:
-
资助金额:$21.38万
-
财政年份:2015
-
负责人:GARY S FIRESTEIN
-
依托单位:
UC San Diego Clinical and Translational Research Institute
-
批准号:10614992
-
项目类别:
-
资助金额:$922.81万
-
财政年份:2015
-
负责人:GARY S FIRESTEIN
-
依托单位:
UC San Diego Clinical and Translational Research Institute
-
批准号:10378449
-
项目类别:
-
资助金额:$14.55万
-
财政年份:2015
-
负责人:GARY S FIRESTEIN
-
依托单位:
High resolution DNA methylation signature in rheumatoid arthritis
-
批准号:8897270
-
项目类别:
-
资助金额:$34.1万
-
财政年份:2014
-
负责人:GARY S FIRESTEIN
-
依托单位:
Identification of key regulators in rheumatoid arthritis
-
批准号:10616695
-
项目类别:
-
资助金额:$58.54万
-
财政年份:2014
-
负责人:GARY S FIRESTEIN
-
依托单位:
High resolution DNA methylation signature in rheumatoid arthritis
-
批准号:8760169
-
项目类别:
-
资助金额:$34.1万
-
财政年份:2014
-
负责人:GARY S FIRESTEIN
-
依托单位:
Identification of key regulators in rheumatoid arthritis
-
批准号:10400059
-
项目类别:
-
资助金额:$59.06万
-
财政年份:2014
-
负责人:GARY S FIRESTEIN
-
依托单位:
Identification of key regulators in rheumatoid arthritis
-
批准号:9976210
-
项目类别:
-
资助金额:$60.5万
-
财政年份:2014
-
负责人:GARY S FIRESTEIN
-
依托单位:
海外基金